{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:47:33Z","timestamp":1792698453265,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.it.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T20:58:13Z","timestamp":1742417893000},"page":"324-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function"],"prefix":"10.1016","volume":"46","author":[{"given":"Shunqun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma H.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-8795","authenticated-orcid":false,"given":"Jonathan S.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2025.02.010_bb0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.02.010_bb0015","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/s41467-020-15857-x","article-title":"CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes","volume":"11","author":"Shimokawa","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2025.02.010_bb0020","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200030","article-title":"TGF-beta and Eomes control the homeostasis of CD8+ regulatory T cells","volume":"218","author":"Mishra","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.02.010_bb0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00262-018-2230-0","article-title":"IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells","volume":"67","author":"Plaumann","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.it.2025.02.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj1738","article-title":"Targeting latency-associated peptide promotes antitumor immunity","volume":"2","author":"Gabriely","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41590-024-02023-4","article-title":"Circulating tumor-reactive KIR+CD8+ T cells suppress anti-tumor immunity in patients with melanoma","volume":"26","author":"Lu","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41590-024-02062-x","article-title":"Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses","volume":"26","author":"Chen","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi9591","article-title":"KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19","volume":"376","author":"Li","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.it.2025.02.010_bb0050","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1073\/pnas.1918950117","article-title":"Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts","volume":"117","author":"Choi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.02.010_bb0055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.2300289","article-title":"Antibody-suppressor CXCR5+CD8+ T cells are more potent regulators of humoral alloimmunity after kidney transplant in mice compared to CD4+ regulatory T cells","volume":"212","author":"Han","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0060","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"Xystrakis","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.02.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101508","article-title":"Plasmacytoid dendritic cells mediate the tolerogenic effect of CD8+ regulatory T cells in a rat tolerant liver transplantation model","volume":"70","author":"Li","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0070","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.1900832","article-title":"Distinct PLZF+CD8alphaalpha+ unconventional T cells enriched in liver use a cytotoxic mechanism to limit autoimmunity","volume":"203","author":"Sheng","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00018-024-05378-x","article-title":"Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease","volume":"81","author":"Fan","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.it.2025.02.010_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2025.02.010_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy","volume":"6","author":"Churlaud","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0095","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.02.010_bb0100","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1182\/blood-2011-12-396119","article-title":"Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation","volume":"119","author":"Robb","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.02.010_bb0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.1200886","article-title":"CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity","volume":"189","author":"Beres","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.2010.04299.x","article-title":"Expansion of regulatory CD8+ CD25+ T cells after neonatal alloimmunization","volume":"163","author":"Adams","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0115","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1182\/blood-2011-07-367987","article-title":"Cell-autonomous role of TGFbeta and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD","volume":"119","author":"Sawamukai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2025.02.010_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210839","article-title":"Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients","volume":"14","author":"Pellegrino","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.02.010_bb0125","doi-asserted-by":"crossref","first-page":"E316","DOI":"10.1002\/lary.28759","article-title":"Influences of CD8+ Tregs on peripheral blood mononuclear cells from allergic rhinitis patients","volume":"131","author":"Lin","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.it.2025.02.010_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2021.12.030","article-title":"TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity","volume":"528","author":"Lozano","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.it.2025.02.010_bb0135","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.celrep.2012.11.016","article-title":"Induction of CD8+ regulatory T cells protects macaques against SIV challenge","volume":"2","author":"Lu","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2025.02.010_bb0140","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4049\/jimmunol.0902955","article-title":"Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control","volume":"184","author":"Nigam","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/eji.201343583","article-title":"CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection","volume":"44","author":"Zou","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd3774","article-title":"Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3+CD8+ Tregs","volume":"6","author":"Joeris","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015373","article-title":"Local induction of immunosuppressive CD8+ T cells in the gut-associated lymphoid tissues","volume":"5","author":"Fleissner","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.02.010_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1126\/science.adh4124","article-title":"CD8 T cell tolerance results from eviction of immature autoreactive cells from the thymus","volume":"382","author":"Badr","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.it.2025.02.010_bb0165","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ijc.25693","article-title":"CD8+ Foxp3+ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response","volume":"129","author":"Le","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.it.2025.02.010_bb0170","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI23961","article-title":"TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs","volume":"115","author":"Bisikirska","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.02.010_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.2009.00775.x","article-title":"Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells","volume":"229","author":"Bour-Jordan","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.it.2025.02.010_bb0180","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1002\/eji.200425143","article-title":"Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function","volume":"34","author":"Tang","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0185","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4049\/jimmunol.1101303","article-title":"ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice","volume":"188","author":"Kornete","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CJI.0b013e3180336787","article-title":"IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells","volume":"30","author":"Ahmadzadeh","year":"2007","journal-title":"J. Immunother."},{"key":"10.1016\/j.it.2025.02.010_bb0195","article-title":"Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits","volume":"219","author":"Whyte","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.02.010_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2025.02.010_bb0205","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","article-title":"Induced regulatory T cells: their development, stability, and applications","volume":"37","author":"Kanamori","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2021.03.020","article-title":"A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance","volume":"54","author":"Dikiy","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.02.010_bb0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"TGF-beta regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004943","article-title":"Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice","volume":"5","author":"Zheng","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2025.02.010_bb0225","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/JLB.5A0122-027R","article-title":"In vitro-induced Foxp3+ CD8+ regulatory T cells suppress allergic IgE response in the gut","volume":"112","author":"Giri","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.it.2025.02.010_bb0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1146842","article-title":"CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice","volume":"5","author":"Heinrichs","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.it.2025.02.010_bb0240","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/bloodadvances.2019000531","article-title":"Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse","volume":"3","author":"Iamsawat","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.it.2025.02.010_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101805","article-title":"CD8+ iTregs mediate the protective effect of rapamycin against graft versus host disease in a humanized murine model","volume":"77","author":"Chen","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.it.2023.04.005","article-title":"Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond","volume":"44","author":"Bittner","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0255","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4049\/jimmunol.180.2.825","article-title":"Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis","volume":"180","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0260","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/eji.201444675","article-title":"IL-15-dependent CD8+ CD122+ T cells ameliorate experimental autoimmune encephalomyelitis by modulating IL-17 production by CD4+ T cells","volume":"44","author":"Yu","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1000800","article-title":"CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis","volume":"186","author":"Endharti","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0270","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI66938","article-title":"Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells","volume":"123","author":"Leavenworth","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.02.010_bb0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.1800976","article-title":"Regulation of diabetogenic immunity by IL-15-activated regulatory CD8 T cells in type 1 diabetes","volume":"203","author":"Stocks","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0280","doi-asserted-by":"crossref","first-page":"21089","DOI":"10.1073\/pnas.1320999110","article-title":"Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection","volume":"110","author":"Holderried","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2025.02.010_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/2326-6066.CIR-13-0121","article-title":"Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity","volume":"2","author":"Alvarez Arias","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.it.2025.02.010_bb0290","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.4049\/jimmunol.1601429","article-title":"STAT4 regulates the CD8+ regulatory T cell\/T follicular helper cell axis and promotes atherogenesis in insulin-resistant Ldlr\u2212\/\u2212 Mice","volume":"199","author":"Taghavie-Moghadam","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0295","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4049\/jimmunol.1000661","article-title":"Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells","volume":"185","author":"Dai","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045234","article-title":"Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-gamma-mediated suppressor activities","volume":"7","author":"Bahri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2025.02.010_bb0305","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.aad0616","article-title":"Stable inhibitory activity of regulatory T cells requires the transcription factor Helios","volume":"350","author":"Kim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.it.2025.02.010_bb0310","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI17935","article-title":"Regulatory functions of CD8+CD28\u2212 T cells in an autoimmune disease model","volume":"112","author":"Najafian","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2025.02.010_bb0315","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1053\/j.gastro.2006.09.008","article-title":"CD8+CD28\u2212 regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice","volume":"131","author":"Menager-Marcq","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.it.2025.02.010_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+ Foxp3\u2212 CD103+ regulatory T cells","volume":"6","author":"Liu","year":"2014","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.it.2025.02.010_bb0325","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature09370","article-title":"Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.it.2025.02.010_bb0330","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/TP.0000000000002683","article-title":"Antibody-suppressor CD8+ T cells require CXCR5","volume":"103","author":"Zimmerer","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.it.2025.02.010_bb0335","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4049\/jimmunol.1000120","article-title":"Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0340","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.4049\/jimmunol.178.10.6043","article-title":"Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis","volume":"178","author":"Tang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0345","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-04-4043","article-title":"Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2025.02.010_bb0350","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-07-0842","article-title":"CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer","volume":"13","author":"Kiniwa","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.it.2025.02.010_bb0355","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00262-012-1277-6","article-title":"Increased tumor-infiltrating CD8+Foxp3+ T lymphocytes are associated with tumor progression in human gastric cancer","volume":"61","author":"Peng","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.it.2025.02.010_bb0360","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QAI.0b013e3181a74fad","article-title":"CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy","volume":"51","author":"Lim","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.it.2025.02.010_bb0365","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.humimm.2010.01.024","article-title":"CD8+Foxp3+ T cells in peripheral blood of relapsing-remitting multiple sclerosis patients","volume":"71","author":"Frisullo","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0370","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","article-title":"Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis","volume":"67","author":"Correale","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2025.02.010_bb0375","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028449","article-title":"The common cytokine receptor gamma chain family of cytokines","volume":"10","author":"Lin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.it.2025.02.010_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2018.00035","article-title":"TGF-beta-Induced CD8+CD103+ regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells","volume":"9","author":"Zhong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0385","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","article-title":"CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor","volume":"16","author":"McHugh","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.it.2025.02.010_bb0390","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0395","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0400","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4049\/jimmunol.1600253","article-title":"Osteoclast-primed Foxp3+ CD8 T cells induce T-bet, Eomesodermin, and IFN-gamma to regulate bone resorption","volume":"197","author":"Shashkova","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0405","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/eji.201040485","article-title":"Acquisition of regulatory function by human CD8+ T cells treated with anti-CD3 antibody requires TNF","volume":"40","author":"Ablamunits","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0410","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0415","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2025.02.010_bb0420","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2025.02.010_bb0425","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1073\/pnas.0710441105","article-title":"Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490625000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:53:17Z","timestamp":1744433597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490625000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1471490625000535"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2025.02.010","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}